Clinical trials search results

Go to PagePage of 9, showing items 21-30 of 87.

Previous Page Next Page

UW15068: UWCCC Precision Medicine Molecular Tumor Board Registry
NRG-HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with Contraindication for Cisplatin.
ECOG EA3161: A Phase II/III Randomized Study of Maintenance Nivolumab vs. Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive Oropharyngeal Carcinoma (OPCA).
NRG-GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Ovarian, Peritoneal
EA4181: A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.)Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients = 70 years old with Untreated Mantle Cell Lymphoma
mantle cell, lymphoma
EAA173: Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
smoldering myeloma
A021703: Randomized Double-blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
metastatic, colon, rectal
SWOG S1803: Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC STUDY)
multiple myeloma, blood cancer
SWOG S1400F: A Phase II Study of MEDI4736 (DURVALUMB) Plus TREMELIMUMAB as Therapy for Patients with Previously Treated ANTI-PD-/PD-L1 Resistant Stage IV Squamous Cell Lung Cancer
Alliance A031704: PD-inhibitor (nivolumab) and Ipilimumab followed by nivolumab vs. VEGF TKI cabozantinib with nivolumab: a phase III trial in metastatic untreated REnal cell cancEr (PDIGREE)

Go to PagePage of 9, showing items 21-30 of 87.

Previous Page Next Page

Contact us

To learn more about clinical trials at ProHealth Care, email research.institute@phci.org or call 262-928-3447.

Quick Access Links